Apellis Pharmaceuticals Financial Overview
Apellis Pharmaceuticals's market cap is currently $3.18B. The company's EPS TTM is $1.67; its P/E ratio is 84.74; Apellis Pharmaceuticals is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
